VS

Victoria Smith

Genentech: 296 patents #5 of 2,392Top 1%
GB Gilead Biologics: 13 patents #1 of 15Top 7%
UD University Of Dundee: 2 patents #28 of 136Top 25%
GS Gilead Sciences: 1 patents #673 of 952Top 75%
Stanford University: 1 patents #115 of 519Top 25%
Overall (All Time): #1,149 of 4,157,543Top 1%
314
Patents All Time

Issued Patents All Time

Showing 25 most recent of 314 patents

Patent #TitleCo-InventorsDate
12421321 Methods for treating fibrodysplasia ossificans progressiva Pankaj Bhargava 2025-09-23
11634505 Antibodies to matrix metalloproteinase 9 Scott McCauley 2023-04-25
10800857 Antibodies to matrix metalloproteinase 9 Scott McCauley 2020-10-13
10494443 LOX and LOXL2 inhibitors and uses thereof Scott Ogg, Peter Van Vlasselaer, Vivian E. Barry, Derek Marshall, Alison Kay Holzer +5 more 2019-12-03
9828346 N-myristoyl transferase inhibitors Stephen Brand, Paul Graham Wyatt, Stephen Thompson, Tracy Bayliss, Justin Harrison +4 more 2017-11-28
9732156 Methods of treating rheumatoid arthritis using antibodies to matrix metalloproteinase 9 Joanne Adamkewicz, Zung THAI, Michael J. Hawkins 2017-08-15
9550836 Method of detecting human matrix metalloproteinase 9 using antibodies Scott McCauley 2017-01-24
9289447 Chemotherapeutic methods and compositions Alison Kay Holzer 2016-03-22
9176139 LOX and LOXL2 inhibitors and uses thereof Scott Ogg, Peter Van Vlasselaer, Vivian E. Barry, Derek Marshall, Alison Kay Holzer +5 more 2015-11-03
9156811 N-myristoyl transferase inhibitors Stephen Brand, Paul Graham Wyatt, Stephen Thompson, Tracy Bayliss, Justin Harrison +4 more 2015-10-13
9107935 Chemotherapeutic methods and compositions Alison Kay Holzer 2015-08-18
9085630 Compositions and methods for the treatment of tumor of hematopoietic origin Craig Crowley, Frederic J. de Sauvage, Dan Eaton, Allen Ebens, Andrew Poison 2015-07-21
8927700 Catalytic domains from lysyl oxidase and LOXL2 Scott McCauley 2015-01-06
8728480 Methods for the treatment of tumors expressing TAT123 or naturally occurring variants thereof Belinda Cairns, Ruihuan Chen, Gretchen Frantz, Kenneth Hillan, Hartmut Koeppen +6 more 2014-05-20
8691222 NLRR-1 antagonists and uses thereof Meredith Hazen, Jo-Anne Hongo, Susanna Y. Stinson 2014-04-08
8680246 Antibodies that bind to lysyl oxidase-like 2 (LOXL2) Scott McCauley, Hector Rodriguez, Carlos Aurelio Garcia 2014-03-25
8679485 Methods and compositions for treatment and diagnosis of fibrosis, tumor invasion, angiogenesis, and metastasis Scott Ogg, Peter Van Vlasselaer, Vivian E. Barry, Derek Marshall, Alison Kay Holzer +5 more 2014-03-25
8658167 Methods and compositions for treatment and diagnosis of fibrosis, tumor invasion, angiogenesis, and metastasis Scott Ogg, Peter Van Vlasselaer, Vivian E. Barry, Derek Marshall, Alison Kay Holzer +5 more 2014-02-25
8563695 Antibodies that bind β2 Jo-Anne Hongo, Jing Li 2013-10-22
8512990 Catalytic domains from lysyl oxidase and LOXL2 Scott McCauley 2013-08-20
8461303 LOX and LOXL2 inhibitors and uses thereof Scott Ogg, Peter Van Vlasselaer, Vivian E. Barry, Derek Marshall, Alison Kay Holzer +5 more 2013-06-11
8398982 Compositions and methods for the diagnosis and treatment of tumor Patrick F. Dowd, Gretchen Frantz, Paul Polakis, Susan D. Spencer, Thomas Wu +1 more 2013-03-19
8388973 Compositions and methods for the treatment of tumor of hematopoietic origin Wesley Chang, Frederic J. de Sauvage, Dan Eaton, Allen Ebens, Gretchen Frantz +3 more 2013-03-05
8278042 Compositions and methods for the diagnosis and treatment of tumor Belinda Cairns, Ruihuan Chen, Gretchen Frantz, Kenneth Hillan, Hartmut Koeppen +6 more 2012-10-02
8106156 PRO1120 polypeptides Audrey Goddard, Paul Godowski, Austin Gurney, William I. Wood 2012-01-31